Healthcare Technology

AI System Detects Pancreatic Cancer Signs Three Years Before Diagnosis

AI System Detects Pancreatic Cancer Signs Three Years Before Diagnosis

Mayo Clinic researchers have developed an AI system that identifies early warning signs of pancreatic cancer up to three years before formal diagnosis, potentially enabling earlier intervention and improved outcomes.

May 8, 2026
AI-Powered Wearables Poised to Transform Healthcare with Actionable Insights

AI-Powered Wearables Poised to Transform Healthcare with Actionable Insights

Advances in artificial intelligence are enabling wearable devices to provide clinicians with actionable insights, moving beyond data collection to drive meaningful healthcare improvements.

May 8, 2026
Lantern Pharma Unveils Multi-Agent AI and Computational Biology Tools for withZeta.ai Platform

Lantern Pharma Unveils Multi-Agent AI and Computational Biology Tools for withZeta.ai Platform

Lantern Pharma announced the next phase of its withZeta.ai platform, including ZetaSwarm and ZetaOmics, which could accelerate oncology research and create a new revenue stream for the company.

May 7, 2026
HeartBeam Expands Concierge Cardiology Footprint with Atelier Health Agreement

HeartBeam Expands Concierge Cardiology Footprint with Atelier Health Agreement

HeartBeam Inc. has signed a commercial agreement with Beverly Hills-based Atelier Health, expanding its launch footprint into Southern California and completing its initial targeted markets for its cable-free 3D ECG technology.

May 7, 2026
Aclarion Expands Commercial Team Amid Triple-Digit Growth in Nociscan Utilization

Aclarion Expands Commercial Team Amid Triple-Digit Growth in Nociscan Utilization

Aclarion granted inducement stock options to its new Western U.S. Commercial Director as demand for its Nociscan platform surges, reflecting strong adoption of its AI-driven chronic low back pain diagnostic tool.

May 6, 2026
MindBio Therapeutics Develops Cross-Language AI Model for Intoxication Detection, Expanding Non-Invasive Safety Screening

MindBio Therapeutics Develops Cross-Language AI Model for Intoxication Detection, Expanding Non-Invasive Safety Screening

MindBio Therapeutics has created a language-agnostic AI speech model that detects drug and alcohol intoxication across multiple languages, enabling scalable, non-invasive testing for high-volume safety screening in industries like mining, aviation, and construction.

May 5, 2026
SS Innovations Surpasses 10,500 Surgeries with SSi Mantra Robotic System, Signaling Growing Global Adoption

SS Innovations Surpasses 10,500 Surgeries with SSi Mantra Robotic System, Signaling Growing Global Adoption

SS Innovations International announced that its SSi Mantra surgical robotic system has been used in over 10,500 procedures across 11 countries, highlighting the system's rapid adoption and potential to democratize robotic surgery.

May 5, 2026
Ventripoint to Showcase AI-Powered Cardiac Imaging at European Paediatric Cardiology Conference

Ventripoint to Showcase AI-Powered Cardiac Imaging at European Paediatric Cardiology Conference

Ventripoint will exhibit its VMS+ 4.0 technology at the AEPC annual meeting, highlighting its potential to improve lifelong care for congenital heart disease patients through accurate, MRI-equivalent assessments from echocardiograms.

May 4, 2026
Aquinas Senior Living Achieves 99.8% Resident Adoption of Teton AI Monitoring Across Pennsylvania Portfolio

Aquinas Senior Living Achieves 99.8% Resident Adoption of Teton AI Monitoring Across Pennsylvania Portfolio

Aquinas Senior Living has scaled Teton's AI-powered monitoring platform across its Pennsylvania communities, achieving near-universal resident adoption and integrating an E-call system to unify fall detection and assistance requests.

May 1, 2026
HeartBeam to Report Q1 2026 Results, Highlight Commercial Launch and AI Initiatives

HeartBeam to Report Q1 2026 Results, Highlight Commercial Launch and AI Initiatives

HeartBeam will host its Q1 2026 earnings call on May 13, providing updates on its limited commercial launch for arrhythmia assessment, extended-wear patch development, heart attack detection, and AI programs.

April 30, 2026
Oncotelic Therapeutics Advances AI and Robotics Platform Toward Initial Commercial Deployment

Oncotelic Therapeutics Advances AI and Robotics Platform Toward Initial Commercial Deployment

Oncotelic Therapeutics reports progress on its proprietary AI platform and robotics integration, aiming to improve efficiency and compliance in pharmaceutical development and manufacturing.

April 30, 2026
MindBio Therapeutics Files Patents for AI Voice Intoxication Detection Technology

MindBio Therapeutics Files Patents for AI Voice Intoxication Detection Technology

MindBio Therapeutics has filed patent applications for its AI-driven voice technology that detects drug and alcohol intoxication, with commercial kiosks for mining and aviation on track for delivery by Q2 2026.

April 29, 2026
HeartBeam Partners with Mount Sinai to Develop AI-Powered ECG Algorithms

HeartBeam Partners with Mount Sinai to Develop AI-Powered ECG Algorithms

HeartBeam Inc. collaborates with Mount Sinai to advance AI-driven ECG technology, aiming to enhance remote cardiac monitoring and chronic condition management.

April 24, 2026
AI System Achieves 100% Antibiotic Prescribing Accuracy in Clinical Trial

AI System Achieves 100% Antibiotic Prescribing Accuracy in Clinical Trial

An AI-powered clinical decision support system called Ask Eolas eliminated antibiotic prescribing errors in a randomized controlled trial, offering a potential solution to the U.S. antibiotic crisis where inappropriate prescribing contributes to millions of resistant infections annually.

April 22, 2026
Perpetuals.com Expands AI Technology from Finance to Healthcare with New Clinical Diagnostic Platform

Perpetuals.com Expands AI Technology from Finance to Healthcare with New Clinical Diagnostic Platform

Perpetuals.com Ltd. is expanding its BayesShield AI technology from financial markets to healthcare with a new clinical diagnostic platform designed to identify physicians with the strongest diagnostic accuracy, potentially reducing bias and improving medical decision-making.

April 22, 2026
Catalyst Crew Technologies Launches Telehealth Platform Targeting Latin American Healthcare Gaps

Catalyst Crew Technologies Launches Telehealth Platform Targeting Latin American Healthcare Gaps

Catalyst Crew Technologies has launched its telehealth platform in Venezuela, aiming to address infrastructure constraints and fragmented care delivery across Latin America through AI-driven healthcare coordination.

April 22, 2026
Aclarion Secures U.S. Patent for AI-Driven Chronic Back Pain Assessment Technology

Aclarion Secures U.S. Patent for AI-Driven Chronic Back Pain Assessment Technology

Aclarion has obtained a U.S. patent for its AI-powered platform that analyzes spinal data to identify sources of chronic low back pain, potentially improving surgical outcomes and expanding access to more consistent diagnostics.

April 22, 2026
Catalyst Crew Technologies Advances Telehealth Platform Development for Latin American Markets

Catalyst Crew Technologies Advances Telehealth Platform Development for Latin American Markets

Catalyst Crew Technologies is developing an AI-integrated telehealth platform focused on emerging markets, starting with Venezuela, to improve healthcare coordination and data-driven insights in regions with growing demand for modernized medical services.

April 22, 2026
NextPlat's PharmcoRx Deploys AI Technology to Automate Pharmacy Prescription Processing

NextPlat's PharmcoRx Deploys AI Technology to Automate Pharmacy Prescription Processing

NextPlat Corp's PharmcoRx subsidiary has implemented AI-powered prescription intake and processing technology to automate manual workflows, improve efficiency, reduce costs, and support scalable growth in pharmacy management.

April 22, 2026
Cardio Diagnostics Holdings Leverages AI and Epigenetics for Advanced Cardiovascular Disease Management

Cardio Diagnostics Holdings Leverages AI and Epigenetics for Advanced Cardiovascular Disease Management

Cardio Diagnostics Holdings is advancing cardiovascular disease prevention and detection through an AI-driven platform that integrates genetics and epigenetics to provide personalized insights.

April 22, 2026
South Ogden Orthodontic Practice Emphasizes Personalized Care and Advanced Technology

South Ogden Orthodontic Practice Emphasizes Personalized Care and Advanced Technology

Albrechtsen & Fanelli Orthodontics in South Ogden provides comprehensive orthodontic services using advanced technology and personalized treatment approaches for both children and adults.

November 14, 2025
LogicMark Introduces AI-Powered Digital Twin Technology to Predict Senior Safety Risks

LogicMark Introduces AI-Powered Digital Twin Technology to Predict Senior Safety Risks

LogicMark's new AI-driven digital twin technology enables proactive senior care by predicting falls and health emergencies before they occur, potentially transforming elderly care from reactive monitoring to preventive intervention.

November 11, 2025
Lantern Pharma CEO Details AI Platform's Role in Accelerating Cancer Drug Development

Lantern Pharma CEO Details AI Platform's Role in Accelerating Cancer Drug Development

Lantern Pharma is using artificial intelligence to significantly reduce the time and cost of oncology drug development while expanding treatment options for cancer patients.

November 10, 2025
Datavault AI Grants Scilex Exclusive License for Biotech Exchange Platform in $2.55 Billion Deal

Datavault AI Grants Scilex Exclusive License for Biotech Exchange Platform in $2.55 Billion Deal

Datavault AI has licensed its AI-driven technology to Scilex for a biotech exchange platform that could address a $2 trillion pharmaceutical market, representing a major advancement in tokenizing and monetizing healthcare assets.

November 6, 2025
HeartBeam Receives Buy Rating and $4 Price Target from Roth Capital, Highlighting FDA Clearance Catalyst

HeartBeam Receives Buy Rating and $4 Price Target from Roth Capital, Highlighting FDA Clearance Catalyst

HeartBeam Inc. received a Buy rating and $4 price target from Roth Capital, which emphasized the company's potential FDA clearance for its 12-lead ECG synthesis software and its position to transform remote cardiac monitoring.

November 6, 2025
SunKnowledge Expands Virtual Medical Assistant Services Nationwide with Cost-Saving Solutions

SunKnowledge Expands Virtual Medical Assistant Services Nationwide with Cost-Saving Solutions

SunKnowledge Inc. is transforming healthcare operations across all 50 states by providing specialized virtual medical assistant services that reduce administrative costs by up to 80% while improving efficiency and patient care.

November 5, 2025
LogicMark CEO Outlines Growth Strategy Through Personal Safety Innovation

LogicMark CEO Outlines Growth Strategy Through Personal Safety Innovation

LogicMark CEO Chia-Lin Simmons discusses the company's SaaS model and innovation-driven growth strategy in the personal emergency response systems market, highlighting how technology is transforming safety solutions for at-risk populations.

November 3, 2025
LogicMark Expands AI-Driven Safety Platform to Capture Growing $147 Billion Market

LogicMark Expands AI-Driven Safety Platform to Capture Growing $147 Billion Market

LogicMark Inc. is leveraging artificial intelligence and a Software-as-a-Service model to transform personal emergency response systems, enabling real-time monitoring for aging adults while positioning the company for recurring revenue streams in the rapidly expanding smart safety market.

October 31, 2025
Yu Galaxy's $500M Solo GP Venture Model Targets High-Impact Investments

Yu Galaxy's $500M Solo GP Venture Model Targets High-Impact Investments

Yu Galaxy's unique solo-GP venture capital approach demonstrates how rapid decision-making and founder-focused support can drive both substantial social impact and financial returns across healthcare, AI, and infrastructure sectors.

October 30, 2025
Izotropic Corporation Featured in Editorial on AI-Driven Breast Cancer Imaging Innovation

Izotropic Corporation Featured in Editorial on AI-Driven Breast Cancer Imaging Innovation

Izotropic Corporation is highlighted in a NetworkNewsWire editorial focusing on how artificial intelligence is transforming breast cancer detection, particularly through the company's IzoView Breast CT Imaging System designed to improve accuracy for women with dense breast tissue.

October 24, 2025
PreviousPage 1 of 5Next